Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06036420 · ClinicalTrials.gov registry record · NA

Flashed Light Therapy for Adolescents With ADHD and Delayed Sleep Timing

A NA study of ADHD, sponsored by University of California, Los Angeles.

Active
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT06036420 is a NA study of ADHD that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 6 participants, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06036420, a NA study of ADHD, is active but no longer recruiting, sponsored by University of California, Los Angeles.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The primary aim of the present research project is to examine the feasibility, as measured by treatment perceptions, and tolerability, as measured by adherence and attrition, of two weeks of flashed light therapy alone followed by four weeks of daily flashed light therapy combined with four weekly videoconference-delivered cognitive behavioral therapy sessions targeting circadian rhythms and sleep in four adolescents aged 14 to 17 years with attention-deficit/hyperactivity disorder and delayed sleep-wake schedules.

Conditions Studied

Interventions

  • DEVICE Flashed Light Therapy
  • BEHAVIORAL Videoconference-delivered Cognitive Behavioral Therapy

Study Locations (1)

California

  • Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2023-10-20
Est. Completion 2027-03-20
Phase NA

What the Registry Record Tells You About NCT06036420

The ClinicalTrials.gov registry entry for NCT06036420 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (97% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 2 interventions - of which Flashed Light Therapy is the first listed.

NCT06036420 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06036420 about?

NCT06036420 is a clinical study titled "Flashed Light Therapy for Adolescents With ADHD and Delayed Sleep Timing". The primary aim of the present research project is to examine the feasibility, as measured by treatment perceptions, and tolerability, as measured by adherence and attrition, of two weeks of flashed light therapy alone followed by four weeks of daily flashed light therapy combined with four weekly v...

What is the current status of trial NCT06036420?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2023-10-20. Estimated completion is 2027-03-20.

What conditions does trial NCT06036420 study?

This clinical trial studies the following conditions: ADHD.

What interventions are being tested in trial NCT06036420?

The interventions under investigation include: Flashed Light Therapy (DEVICE), Videoconference-delivered Cognitive Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06036420?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06036420 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ADHD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.